Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Phloretin Exerts Anti-Tuberculosis Activity and Suppresses Lung Inflammation.

Jeon D, Jeong MC, Jnawali HN, Kwak C, Ryoo S, Jung ID, Kim Y.

Molecules. 2017 Jan 22;22(1). pii: E183. doi: 10.3390/molecules22010183.

2.

Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin.

Jnawali HN, Jeon D, Jeong MC, Lee E, Jin B, Ryoo S, Yoo J, Jung ID, Lee SJ, Park YM, Kim Y.

J Nat Prod. 2016 Apr 22;79(4):961-9. doi: 10.1021/acs.jnatprod.5b01033. Epub 2016 Mar 14.

PMID:
26974691
3.

Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.

Lee E, Shin A, Jeong KW, Jin B, Jnawali HN, Shin S, Shin SY, Kim Y.

PLoS One. 2014 Dec 4;9(12):e114453. doi: 10.1371/journal.pone.0114453. eCollection 2014.

4.

Cytotoxic activity of 3,6-dihydroxyflavone in human cervical cancer cells and its therapeutic effect on c-Jun N-terminal kinase inhibition.

Lee E, Jeong KW, Jnawali HN, Shin A, Heo YS, Kim Y.

Molecules. 2014 Aug 27;19(9):13200-11. doi: 10.3390/molecules190913200.

5.

Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.

Jnawali HN, Lee E, Jeong KW, Shin A, Heo YS, Kim Y.

J Nat Prod. 2014 Feb 28;77(2):258-63. doi: 10.1021/np400803n. Epub 2014 Jan 7.

PMID:
24397781
6.

Binding model for eriodictyol to Jun-N terminal kinase and its anti-inflammatory signaling pathway.

Lee E, Jeong KW, Shin A, Jin B, Jnawali HN, Jun BH, Lee JY, Heo YS, Kim Y.

BMB Rep. 2013 Dec;46(12):594-9.

7.

Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.

Jnawali HN, Hwang SC, Park YK, Kim H, Lee YS, Chung GT, Choe KH, Ryoo S.

Diagn Microbiol Infect Dis. 2013 Jun;76(2):187-96. doi: 10.1016/j.diagmicrobio.2013.02.035. Epub 2013 Apr 2.

PMID:
23561273
8.

Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Jnawali HN, Yoo H, Ryoo S, Lee KJ, Kim BJ, Koh WJ, Kim CK, Kim HJ, Park YK.

World J Microbiol Biotechnol. 2013 Jun;29(6):975-82. doi: 10.1007/s11274-013-1256-x. Epub 2013 Jan 18.

PMID:
23329063
9.

Correlation of the phenotypic ethambutol susceptibility of Mycobacterium tuberculosis with embB gene mutations in Korea.

Park YK, Ryoo SW, Lee SH, Jnawali HN, Kim CK, Kim HJ, Kim SJ.

J Med Microbiol. 2012 Apr;61(Pt 4):529-34. doi: 10.1099/jmm.0.037614-0. Epub 2011 Dec 15.

PMID:
22174373
10.

Improvement of clavulanic acid production in Streptomyces clavuligerus by genetic manipulation of structural biosynthesis genes.

Jnawali HN, Yoo JC, Sohng JK.

Biotechnol Lett. 2011 Jun;33(6):1221-6. doi: 10.1007/s10529-011-0561-4. Epub 2011 Feb 20.

PMID:
21336973
11.

Superoxide dismutase (SOD) genes in Streptomyces peucetius: effects of SODs on secondary metabolites production.

Kanth BK, Jnawali HN, Niraula NP, Sohng JK.

Microbiol Res. 2011 Jul 20;166(5):391-402. doi: 10.1016/j.micres.2010.07.003. Epub 2010 Oct 2.

12.

Role of σ-factor (orf21) in clavulanic acid production in Streptomyces clavuligerus NRRL3585.

Jnawali HN, Liou K, Sohng JK.

Microbiol Res. 2011 Jul 20;166(5):369-79. doi: 10.1016/j.micres.2010.07.005. Epub 2010 Sep 25.

13.
14.

Functional characterization of kanB by complementing in engineered Streptomyces fradiae Deltaneo6::tsr.

Jnawali HN, Subba B, Liou K, Sohng JK.

Biotechnol Lett. 2009 Jun;31(6):869-75. doi: 10.1007/s10529-009-9937-0. Epub 2009 Feb 15.

PMID:
19219581
15.

A two-component regulatory system involved in clavulanic acid production.

Jnawali HN, Oh TJ, Liou K, Park BC, Sohng JK.

J Antibiot (Tokyo). 2008 Nov;61(11):651-9. doi: 10.1038/ja.2008.92.

PMID:
19168979

Supplemental Content

Loading ...
Support Center